These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
302 related items for PubMed ID: 9553055
1. Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration. White JR, Lee JM, Young PR, Hertzberg RP, Jurewicz AJ, Chaikin MA, Widdowson K, Foley JJ, Martin LD, Griswold DE, Sarau HM. J Biol Chem; 1998 Apr 24; 273(17):10095-8. PubMed ID: 9553055 [Abstract] [Full Text] [Related]
2. The CXC chemokines growth-regulated oncogene (GRO) alpha, GRObeta, GROgamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor. Ahuja SK, Murphy PM. J Biol Chem; 1996 Aug 23; 271(34):20545-50. PubMed ID: 8702798 [Abstract] [Full Text] [Related]
3. Granulocyte chemotactic protein 2 acts via both IL-8 receptors, CXCR1 and CXCR2. Wolf M, Delgado MB, Jones SA, Dewald B, Clark-Lewis I, Baggiolini M. Eur J Immunol; 1998 Jan 23; 28(1):164-70. PubMed ID: 9485196 [Abstract] [Full Text] [Related]
4. Differential usage of the CXC chemokine receptors 1 and 2 by interleukin-8, granulocyte chemotactic protein-2 and epithelial-cell-derived neutrophil attractant-78. Wuyts A, Proost P, Lenaerts JP, Ben-Baruch A, Van Damme J, Wang JM. Eur J Biochem; 1998 Jul 01; 255(1):67-73. PubMed ID: 9692902 [Abstract] [Full Text] [Related]
5. Rabbit neutrophil chemotactic protein (NCP) activates both CXCR1 and CXCR2 and is the functional homologue for human CXCL6. Catusse J, Struyf S, Wuyts A, Weyler M, Loos T, Gijsbers K, Gouwy M, Proost P, Van Damme J. Biochem Pharmacol; 2004 Nov 15; 68(10):1947-55. PubMed ID: 15476666 [Abstract] [Full Text] [Related]
6. Mast cell migratory response to interleukin-8 is mediated through interaction with chemokine receptor CXCR2/Interleukin-8RB. Nilsson G, Mikovits JA, Metcalfe DD, Taub DD. Blood; 1999 May 01; 93(9):2791-7. PubMed ID: 10216072 [Abstract] [Full Text] [Related]
7. A synthetic, non-peptide CXCR2 antagonist blocks MIP-2-induced neutrophil migration in mice. Matzer SP, Zombou J, Sarau HM, Röllinghoff M, Beuscher HU. Immunobiology; 2004 May 01; 209(3):225-33. PubMed ID: 15518334 [Abstract] [Full Text] [Related]
9. Elucidation of Distinct Roles of Guinea Pig CXCR1 and CXCR2 in Neutrophil Migration toward IL-8 and GROα by Specific Antibodies. Tanaka K, Yoshitomi T, Hirahara K. Biol Pharm Bull; 2017 May 01; 40(5):729-732. PubMed ID: 28458362 [Abstract] [Full Text] [Related]
10. A potent and selective nonpeptide antagonist of CXCR2 inhibits acute and chronic models of arthritis in the rabbit. Podolin PL, Bolognese BJ, Foley JJ, Schmidt DB, Buckley PT, Widdowson KL, Jin Q, White JR, Lee JM, Goodman RB, Hagen TR, Kajikawa O, Marshall LA, Hay DW, Sarau HM. J Immunol; 2002 Dec 01; 169(11):6435-44. PubMed ID: 12444152 [Abstract] [Full Text] [Related]
11. Serum amyloid A1α induces paracrine IL-8/CXCL8 via TLR2 and directly synergizes with this chemokine via CXCR2 and formyl peptide receptor 2 to recruit neutrophils. De Buck M, Berghmans N, Pörtner N, Vanbrabant L, Cockx M, Struyf S, Opdenakker G, Proost P, Van Damme J, Gouwy M. J Leukoc Biol; 2015 Dec 01; 98(6):1049-60. PubMed ID: 26297794 [Abstract] [Full Text] [Related]
12. Combined anti CXC receptors 1 and 2 therapy is a promising anti-inflammatory treatment for respiratory diseases by reducing neutrophil migration and activation. Planagumà A, Domènech T, Pont M, Calama E, García-González V, López R, Aulí M, López M, Fonquerna S, Ramos I, de Alba J, Nueda A, Prats N, Segarra V, Miralpeix M, Lehner MD. Pulm Pharmacol Ther; 2015 Oct 01; 34():37-45. PubMed ID: 26271598 [Abstract] [Full Text] [Related]
13. Neutrophil chemotaxis caused by chronic obstructive pulmonary disease alveolar macrophages: the role of CXCL8 and the receptors CXCR1/CXCR2. Kaur M, Singh D. J Pharmacol Exp Ther; 2013 Oct 01; 347(1):173-80. PubMed ID: 23912333 [Abstract] [Full Text] [Related]
14. Differential cross-regulation of the human chemokine receptors CXCR1 and CXCR2. Evidence for time-dependent signal generation. Richardson RM, Pridgen BC, Haribabu B, Ali H, Snyderman R. J Biol Chem; 1998 Sep 11; 273(37):23830-6. PubMed ID: 9726994 [Abstract] [Full Text] [Related]
15. The CXC-chemokine neutrophil-activating peptide-2 induces two distinct optima of neutrophil chemotaxis by differential interaction with interleukin-8 receptors CXCR-1 and CXCR-2. Ludwig A, Petersen F, Zahn S, Götze O, Schröder JM, Flad HD, Brandt E. Blood; 1997 Dec 01; 90(11):4588-97. PubMed ID: 9373270 [Abstract] [Full Text] [Related]
16. CXCR2 stimulation primes CXCR1 [Ca2+]i responses to IL-8 in human neutrophils. Hauser CJ, Fekete Z, Goodman ER, Kleinstein E, Livingston DH, Deitch EA. Shock; 1999 Dec 01; 12(6):428-37. PubMed ID: 10588510 [Abstract] [Full Text] [Related]
17. The biologic role of interleukin-8: functional analysis and expression of CXCR1 and CXCR2 on human eosinophils. Petering H, Götze O, Kimmig D, Smolarski R, Kapp A, Elsner J. Blood; 1999 Jan 15; 93(2):694-702. PubMed ID: 9885232 [Abstract] [Full Text] [Related]
18. A His19 to Ala mutant of melanoma growth-stimulating activity is a partial antagonist of the CXCR2 receptor. Baly DL, Horuk R, Yansura DG, Simmons LC, Fairbrother WJ, Kotts C, Wirth CM, Gillece-Castro BL, Toy K, Hesselgesser J, Allison DE. J Immunol; 1998 Nov 01; 161(9):4944-9. PubMed ID: 9794430 [Abstract] [Full Text] [Related]
19. Metalloproteinases are involved in lipopolysaccharide- and tumor necrosis factor-alpha-mediated regulation of CXCR1 and CXCR2 chemokine receptor expression. Khandaker MH, Mitchell G, Xu L, Andrews JD, Singh R, Leung H, Madrenas J, Ferguson SS, Feldman RD, Kelvin DJ. Blood; 1999 Apr 01; 93(7):2173-85. PubMed ID: 10090924 [Abstract] [Full Text] [Related]
20. Peripheral blood neutrophils are hyperresponsive to IL-8 and Gro-alpha in cryptogenic fibrosing alveolitis. Glynn PC, Henney EM, Hall IP. Eur Respir J; 2001 Sep 01; 18(3):522-9. PubMed ID: 11589350 [Abstract] [Full Text] [Related] Page: [Next] [New Search]